EU approves AbbVie's Tepkinly combo for follicular lymphoma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. NOW
4. TXN
5. AMD
6. GOOG
7. INTC
8. CSX
9. KNX
10. IBM

Go back to EU approves AbbVie's Tepkinly combo for follicular lymphoma
AbbVie (NYSE: ABBV) Delayed: 256.92 +3.62 (1.43%)
Previous Close $253.30    52 Week High $68.12 
Open $253.98    52 Week Low $50.71 
Day High $258.38    P/E 55.73 
Day Low $253.10    EPS $4.61 
Volume 4,410,093